InsidersTradesSigma
Total declarations
Company
▲ Purchases (18 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Patel Snehal, Chairman & CEO. Director active across 1 company, notably Greenwich LifeSciences, Inc.. In total, 18 disclosures have been published. Split: 18 buys · 0 sell. Total volume traded: €1.1m. History available since 14 December 2021. The latest transaction was filed on 16 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
8,000 shares@ US$7.130.014% mcap4.9% of flowCommon StockSEC:0001493152-22-017036:0
Ideal exit: 13 Mar 2023 (T+270)
12,000 shares@ US$7.910.024% mcap8.2% of flowCommon StockSEC:0001493152-22-016793:0
Ideal exit: 11 Mar 2023 (T+270)
12,000 shares@ US$8.330.025% mcap8.5% of flowCommon StockSEC:0001493152-22-016504:0
Ideal exit: 7 Mar 2023 (T+270)
4,500 shares@ US$10.900.012% mcap4.2% of flowCommon StockSEC:0001493152-22-016372:0
Ideal exit: 6 Mar 2023 (T+270)
6,000 shares@ US$8.550.013% mcap4.3% of flowCommon StockSEC:0001493152-22-016131:0
Ideal exit: 4 Mar 2023 (T+270)
9,250 shares@ US$8.350.019% mcap6.5% of flowCommon StockSEC:0001493152-22-015921:0
Ideal exit: 28 Feb 2023 (T+270)
6,774 shares@ US$7.380.012% mcap4.2% of flowCommon StockSEC:0001493152-22-015769:0
Ideal exit: 27 Feb 2023 (T+270)
6,000 shares@ US$16.090.024% mcap8.0% of flowCommon StockSEC:0001493152-22-010677:0
Ideal exit: 16 Jan 2023 (T+270)
6,000 shares@ US$16.740.025% mcap8.4% of flowCommon StockSEC:0001493152-22-010575:0
Ideal exit: 14 Jan 2023 (T+270)
5,500 shares@ US$19.800.025% mcap8.6% of flowCommon StockSEC:0001493152-22-004178:0
Ideal exit: 8 Nov 2022 (T+270)
5,000 shares@ US$19.590.023% mcap7.7% of flowCommon StockSEC:0001213900-22-005787:0
Ideal exit: 1 Nov 2022 (T+270)
5,000 shares@ US$19.590.023% mcap45.0% of flowCommon StockSEC:0001213900-22-005787
Ideal exit: 1 Nov 2022 (T+270)
1,000 shares@ US$19.990.0046% mcap1.6% of flowCommon StockSEC:0001493152-22-001375:0
Ideal exit: 10 Oct 2022 (T+270)
1,000 shares@ US$19.990.0046% mcap9.2% of flowCommon StockSEC:0001493152-22-001375
Ideal exit: 10 Oct 2022 (T+270)
2,050 shares@ US$23.81990.011% mcap22.6% of flowCommon StockSEC:0001493152-22-000212
Ideal exit: 30 Sept 2022 (T+270)
2,050 shares@ US$23.81990.011% mcap3.9% of flowCommon StockSEC:0001493152-22-000212:0
Ideal exit: 30 Sept 2022 (T+270)
1,840 shares@ US$27.16980.012% mcap23.3% of flowCommon StockSEC:0001493152-21-031655
Ideal exit: 10 Sept 2022 (T+270)
1,840 shares@ US$27.16980.012% mcap4.0% of flowCommon StockSEC:0001493152-21-031655:0
Ideal exit: 10 Sept 2022 (T+270)
18 of 18 declarations
About Patel Snehal
Snehal Patel is an executive at Greenwich LifeSciences, Inc.
